Company / Working Capital
Phathom Pharmaceuticals, Inc. Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$96.9M
FY2025
5-year range
$96.9M / $358.7M
FY2021-FY2025
Trend
-64.7%
vs FY2024
Sector context
#196 of 213
Health Care
What the data says
Among 213 Health Care companies, Phathom Pharmaceuticals, Inc. is in the bottom 8% for working capital. Working Capital has fluctuated over the past 8 years, ranging from -$1M in FY2018 to $359M in FY2023.
Based on SEC 10-K filings.
$97M in FY2025 with a 5-year CAGR of -16.3%.
Declined from $359M to $97M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -10.3%
- 5-Year CAGR
- -16.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 213This company $96.9M Sector average $934.6M
▼
-89.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -16.3%, indicating a declining trend.
- In FY2025, working capital decreased 64.7% year-over-year.
- Ranks #196 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $96.9M | -64.7% |
| FY2024 | $274.4M | -23.5% |
| FY2023 | $358.7M | +167.1% |
| FY2022 | $134.3M | -19.9% |
| FY2021 | $167.6M | -28.9% |
| FY2020 | $235.8M | -6.4% |
| FY2019 | $251.9M | +19684.2% |
| FY2018 | -$1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026